TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2025

Treatment-Free Survival Over 6 Years of Follow-up in Patients With Metastatic NSCLC Treated With First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy in CheckMate 227 Part 1.

Solange Peters et al.PubMed ↗Publisher ↗

No numbers read from the abstract.